The saliva of the Gila monster creates a substance that looks very similar to the GLP-1 our body naturally makes, explains Andrea Traina, PharmD, obesity medical director for Novo Nordisk
Until now, no studies have compared the cost-effectiveness of obesity medications in adolescent patients
Taking breaks between cycles allows assessment of whether continued use remains necessary and gives the body time to normalize
Your Next Steps How to Get Started A simple path to personalized carefrom a quick intake to a clinician-guided plan
For patients wanting comprehensive weight loss support including coaching, meal planning, and behavioral interventions, bundled platforms provide better value despite higher prices
Results Trial population Of 616 individuals entering the 2-week run-in, 135 men and 429 women ( n =564) were randomized to treatment, 398 entered the extension and 268/398 (67%) completed 2 years (see Supplementary Figure 1)